August 30, 2016 6:42 PM ET

Pharmaceuticals

Company Overview of Merck & Co., Inc.

Executive Profile

Roger M. Perlmutter M.D., Ph.D.

Executive Vice President and President of Merck Research Laboratories, Merck & Co., Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 7 different industries.

See Board Relationships
64$8,301,257
As of Fiscal Year 2015

Background

Dr. Roger M. Perlmutter, M.D., Ph.D., has been an Executive Vice President at Merck & Co., Inc. since April 15, 2013. Dr. Perlmutter also has been the President of Merck Research Laboratories since April 15, 2013. He serves as Science Partner at The Column Group LLC. Dr. Perlmutter was a Professor in the Departments of Immunology, Biochemistry and Medicine at the University of Washington in Seattle from January 1991 to January 1997. From 1981 to 1984, he was a Lecturer ...

Corporate Headquarters

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships

Director

Education

Unknown/Other Education 1973
Reed College
PhD 1979
Washington University, St. Louis
MD 1979
Washington University, St. Louis

Other Affiliations

Annual Compensation

Salary$1,021,926
Total Annual Compensation$1,021,926

Stocks Options

Restricted Stock Awards$3,335,960
All Other Compensation$140,416
Exercisable Options$214,484
Exercisable Options Value$1,178,305
Unexercisable Options$451,209
Unexercisable Options Value$589,168
Total Value of Options$1,767,473
Total Number of Options$665,693

Total Compensation

Total Annual Cash Compensation$3,109,042
Total Short Term Compensation$1,021,926
Other Long Term Compensation$3,476,376
Total Calculated Compensation$8,301,257
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$3.3M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Olivier Brandicourt M.D.Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
$2.4M
Jean-Paul Agon Chairman of the Board, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee
L'Oreal SA
$4.0M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Merck & Co., Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.